Samit Kumar Bhattacharya

This inventor holds 20 USPTO granted patents and 15 published patent applications, plus 8 CIPO patents and 3 EPO patents, primarily in Cancer Treatment. Top assignees: Pfizer Corporation, Osi Pharmaceuticals, Inc., Pfizer Products Inc.. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samit Kumar Bhattacharya. Retrieved from https://idiyas.com/inventor/samit-kumar-bhattacharya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 15)

% Patents Active = 65.0

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 6.2

ph-index = 9

Forward Citations = 230(Granted Patents)

Location History:

Groton, CT (US) (2001 - 2010)
Niantic, CT (US) (2011 - 2019)
Waltham, MA (US) (2014 - 2023)

Company Filing History:

Osi Pharmaceuticals, Inc.

4. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

BCKDK Inhibitors

Anti-Proliferative Agents

Sulfonyl Amide Derivatives

Indole Compounds

Indazole Compounds

Pyrimidine Derivatives

Bicyclic Derivatives

Heteroaromatic Compounds

Cancer Therapeutics

Cell Growth Inhibition

AMPK Activation

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12715863 - 5-(thiophen-2-yl)-1 H-tetrazole derivative as BCKDK inhibitors useful for treating various diseases (2026-08-25),

2. 11542270 - BCKDK inhibitors (2023-01-03),

3. 11203594 - Anti-proliferative agents for treating PAH (2021-12-21),

4. 11059833 - BCKDK inhibitors (2021-07-13),

5. 10450297 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2019-10-22),

6. 9394285 - Indole and indazole compounds that activate AMPK (2016-07-19),

7. 8889730 - Indole and indazole compounds that activate AMPK (2014-11-18),

8. 8609680 - 2,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives (2013-12-17),

9. 8440822 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2013-05-14),

10. 8247411 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2012-08-21),

11. 7928109 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2011-04-19),

12. 7820648 - Pyrimidine derivatives for the treatment of abnormal cell growth (2010-10-26),

13. 7585869 - Substituted heterocylces for the treatment of abnormal cell growth (2009-09-08),

14. 7332493 - Substituted bicyclic derivatives for the treatment of abnormal cell growth (2008-02-19),

15. 6927220 - Bicyclic-substituted 4-amino-pyridopyrimidine derivatives (2005-08-09),

Title: The Innovative Journey of Samit Kumar Bhattacharya

Introduction:

Samit Kumar Bhattacharya, a talented inventor hailing from Groton, CT (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Samit Kumar Bhattacharya's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights:

With a career spanning over two decades, Samit Kumar Bhattacharya has worked for renowned tech companies, leading research institutions, and universities, where he has spearheaded numerous projects that have revolutionized the industry.

Collaborations:

Throughout his career, Samit Kumar Bhattacharya has collaborated with top-tier scientists, engineers, and researchers from around the globe, fostering a culture of innovation and excellence in all his projects.

Conclusion:

In conclusion, Samit Kumar Bhattacharya's passion for innovation, coupled with his dedication to pushing the boundaries of technology, has solidified his position as a pioneering inventor in the ever-evolving world of patents and inventions.

Profile summary based on public USPTO records.